RKDA
Arcadia Biosciences, Inc.3.6400
-0.0300-0.82%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
5.00MP/E (TTM)
-Basic EPS (TTM)
-3.69Dividend Yield
0%Recent Filings
10-K
8-K
8-K
Two directors resign abruptly
Arcadia Biosciences lost two board directors—Albert D. Bolles, Ph.D., and Deborah Carosella—both Compensation Committee members, effective February 4, 2026. Bolles also sat on Compensation; Carosella added Nominating and Governance duties. Resignations stemmed from no disagreements on operations or finances. Both will advise informally. Board shrinks suddenly.
8-K
Option exercise yields $2.1M
Arcadia Biosciences induced investors to exercise 808,595 existing options at a reduced $2.575 per share, netting ~$2.1M gross proceeds on January 12, 2026, for working capital. In exchange, it issued new options for 1,617,190 shares at $2.325, exercisable immediately but expiring in 30 months post-resale registration. Cash bolsters liquidity, yet dilutes shareholders further. Locks out variable deals for a year.
8-K
Merger terminated; alternatives eyed.
Roosevelt Resources terminated the Securities Exchange Agreement with Arcadia Biosciences on December 24, 2025, after the August 15 closing deadline passed without completion. No breakup fee applies. Arcadia now resumes pursuing strategic alternatives, touting its 2.7 million Above Food shares, Zola brand growth, and Nasdaq listing. Funding remains tight.
IPO
Website
Employees
Sector
Industry
ABVE
Above Food Ingredients Inc.
1.83+0.07
ARHUF
AAK AB
27.50+0.00
ARRT
Artisan Consumer Goods, Inc.
0.35+0.00
BDPT
Bioadaptives, Inc.
0.03+0.00
BHST
BioHarvest Sciences Inc.
5.50+0.30
DDC
DDC Enterprise Limited
2.27-0.02
GLUC
Glucose Health, Inc.
0.14+0.00
NATR
Nature's Sunshine Products, Inc
22.38-0.85
NPRFF
NEPRA FOODS INC.
0.10+0.00
SDSYA
SOUTH DAKOTA SOYBEAN PROCESSORS
7.00+0.00